United States News All stories

Palantir Technologies (NASDAQ:PLTR) today announced a five-year renewal and expansion of its strategic partnership with Stellantis (NYSE:STLA).

Rio Tinto Group (NYSE:RIO), the world’s leading iron ore producer, announced Monday that it has resumed ship loading at the majority of its Pilbara port terminals following a temporary suspension caused by Tropical Cyclone Narelle.

Rio Tinto (ASX:RIO) has initiated legal proceedings against the United States, seeking a refund of millions in tariffs following a landmark Supreme Court ruling.

Rocket Pharmaceuticals (NASDAQ:RCKT), a leading biotechnology firm specializing in genetic therapies for rare disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for KRESLADI™ (marnetegragene autotemcel).

enVVeno Medical (NASDAQ:NVNO), a clinical-stage medical device company developing innovative solutions for the treatment of chronic venous insufficiency (CVI), today reported its financial results for the full year ended December 31, 2025.

United-Guardian (NASDAQ:UG), a diversified manufacturer of pharmaceutical, cosmetic, and healthcare products, today reported its financial results for the full year ended December 31, 2025.

Carnival (NYSE:CCL), the world’s largest leisure travel company, today reported record-breaking financial results for the first quarter of 2026, signaling a robust start to the fiscal year.

Adagio Medical Holdings (NASDAQ:ADGM), a specialist in catheter ablation technologies for cardiac arrhythmias, reported a substantial narrowing of its net loss for the fiscal year ended Dec. 31, 2025, as the company realized the benefits of an aggressive cost-reduction strategy and a streamlined corporate profile.

Hydrofarm Holdings Group (NASDAQ:HYFM), a leading independent distributor and manufacturer of controlled environment agriculture (CEA) equipment and supplies, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

TMC the metals company (NASDAQ:TMC), a company focused on collecting polymetallic nodules from the deep seabed to supply critical battery metals, reported its fourth-quarter and full-year 2025 financial results along with a corporate update on March 27, 2026.

Werewolf Therapeutics (NASDAQ:HOWL), an innovative biopharmaceutical company developing "inducible" cytokines to treat cancer, today announced it has initiated a formal process to explore strategic alternatives.

Satellos Bioscience (NASDAQ:MSLE), a biotechnology company focused on developing small-molecule therapies that modulate muscle stem cell regeneration, reported its full-year 2025 financial results and provided updates on recent corporate and clinical milestones.

Humacyte (NASDAQ:HUMA), a pioneer in universally implantable, bioengineered human tissues, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

Autolus Therapeutics (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today reported its financial results for the fourth quarter and full year ended December 31, 2025.

Super League (NASDAQ:SLE), a creator and publisher of content experiences and media solutions across the world’s largest immersive platforms, today reported record-breaking financial results for the fourth quarter and full year ended December 31, 2025.

51Talk Online Education Group (NYSE:COE), a leading global online English education platform, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025.

LM Funding America (NASDAQ:LMFA), a cryptocurrency mining and specialty finance company, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

BioXcel Therapeutics (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today reported its financial results for the fourth quarter and full year ended December 31, 2025.

Instil Bio (NASDAQ:TIL), a clinical-stage biopharmaceutical company, today reported its financial results for the fourth quarter and full year ended December 31, 2025, while outlining a transformative shift in its corporate strategy.

AstraZeneca (NASDAQ:AZN) today announced positive high-level results from the OBERON and TITANIA Phase III trials, marking a historic milestone in the treatment of chronic obstructive pulmonary disease (COPD).

Legence (NASDAQ:LGN), a preeminent integrated provider of energy efficiency and sustainability solutions for the built environment, today reported record-breaking financial results for the fourth quarter and full year ended December 31, 2025.

SBC Medical Group Holdings (NASDAQ:SBC), a leading Management Services Organization (MSO) for a diverse range of medical franchises, today announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025.

Novo Nordisk (NYSE:NVO) today announced that the U.S. Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae), the first and only once-weekly, long-acting basal insulin for adults living with type 2 diabetes.

Gravity (NASDAQ:GRVY), a developer and publisher of online and mobile games, today announced its consolidated financial results for the fiscal year ended December 31, 2025.